MAPK1 and tuberous sclerosis: In addition, the finding that ERK regulates protein synthesis via modulation of GSK3β activity in an Akt/mTORC1-independent manner provides a new regulatory pathway that could be exploited for combinatorial therapeutic interventions in tuberous sclerosis.